Healthcare - Biotechnology - NASDAQ - US
$ 42.18
-15.6 %
$ 5.03 B
Market Cap
-14.65
P/E
BALANCE SHEET
629 M
ASSETS
128 M
LIABILITIES
501 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Avidity Biosciences, Inc.
| Current Assets | 611 M |
| Cash & Short-Term Investments | 595 M |
| Receivables | 8.62 M |
| Other Current Assets | 7.33 M |
| Non-Current Assets | 17.2 M |
| Long-Term Investments | 0 |
| PP&E | 16.7 M |
| Other Non-Current Assets | 596 K |
| Current Liabilities | 80.7 M |
| Accounts Payable | 8.81 M |
| Short-Term Debt | 7.28 M |
| Other Current Liabilities | 64.6 M |
| Non-Current Liabilities | 47.1 M |
| Long-Term Debt | 12.4 M |
| Other Non-Current Liabilities | 34.7 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 185.1 | 340.4 | 405.5 | 328.1 | 94.6 | 3.1 |
| Short Term Investments | 410.3 | 270.3 | 85.1 | 6.7 | 0 | 0 |
| Receivables | 8.6 | 0 | 0.9 | 1.2 | 0 | 0 |
| Inventory | 0 | 1 | (0.9) | (1.2) | 1 | 0 |
| Other Current Assets | 7.3 | 8.3 | 5.6 | 3.5 | 1.1 | 0.3 |
| Total Current Assets | 611.3 | 622.9 | 411.1 | 331.7 | 95.7 | 3.2 |
| PP&E | 16.7 | 15.0 | 15.6 | 1.5 | 0.6 | 0.7 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.3 | 0.3 | 0.3 | 0 | 0 |
| Other Long Term Assets | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 38 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 628.6 | 638.8 | 427.6 | 333.9 | 96.9 | 4.0 |
| LIABILITIES | ||||||
| Accounts Payable | 8.8 | 4.6 | 2.8 | 7.7 | 2.3 | 1.6 |
| Short Term Debt | 7.3 | 6.2 | 3.5 | 0 | 2.8 | 2.7 |
| Other Current Liabilities | 36.2 | 60.9 | 28.0 | 3.2 | 1.3 | 0.3 |
| Total Current Liabilities | 80.7 | 51.9 | 29.7 | 14.6 | 10.2 | 4.6 |
| Long Term Debt | 12.4 | 15.2 | 19.9 | 1.9 | 2.2 | 7.6 |
| Deferred Tax Income | 0 | (1.2) | (6.5) | (12.2) | 134.7 | 0 |
| Other Liabilities | (6.2) | (7.6) | (10.0) | (0.9) | 45 K | 32.9 |
| Total Liabilities | 127.8 | 60.7 | 46.1 | 27.7 | 162.3 | 45.1 |
| EQUITY | ||||||
| Common Stock | 8 K | 7 K | 5 K | 4 K | 1 K | 0.4 |
| Retained Earnings | (570.8) | (358.5) | (184.5) | (66.5) | (22.2) | (41.6) |
| Other Accumulative Comprehensive Income/Loss | 0.1 | (2.7) | (0.2) | 5 K | (134.7) | (33.1) |
| Total Equity | 500.8 | 578.1 | 381.4 | 306.2 | (65.4) | (41.1) |
| Total Liabilities and Equity | 628.6 | 638.8 | 427.6 | 333.9 | 96.9 | 4.0 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 73.0 | 52.2 | 41.4 | 21.7 | 37.5 | 20.7 |